ACIW vs. BMY
ACIW (ACI Worldwide, Inc.) and BMY (Bristol-Myers Squibb Company) are both stocks. ACIW operates in Software - Infrastructure (Technology), while BMY operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, ACIW returned 8.12%/yr vs 1.00%/yr for BMY. At a 0.21 correlation, their price movements are largely independent.
Performance
ACIW vs. BMY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ACIW achieves a -5.38% return, which is significantly lower than BMY's 8.27% return. Over the past 10 years, ACIW has outperformed BMY with an annualized return of 8.12%, while BMY has yielded a comparatively lower 1.00% annualized return.
ACIW
- 1D
- 1.98%
- 1M
- 10.69%
- YTD
- -5.38%
- 6M
- -4.82%
- 1Y
- 0.38%
- 3Y*
- 24.77%
- 5Y*
- 2.83%
- 10Y*
- 8.12%
BMY
- 1D
- 0.40%
- 1M
- 0.63%
- YTD
- 8.27%
- 6M
- 11.43%
- 1Y
- 20.57%
- 3Y*
- 0.45%
- 5Y*
- 0.73%
- 10Y*
- 1.00%
ACIW vs. BMY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ACIW ACI Worldwide, Inc. | -5.38% | -7.90% | 69.64% | 33.04% | -33.72% | -9.71% | 1.43% | 36.94% | 22.06% | 24.90% |
BMY Bristol-Myers Squibb Company | 8.27% | 0.11% | 15.81% | -26.14% | 18.98% | 2.88% | 0.41% | 27.74% | -12.90% | 7.71% |
Correlation
The correlation between ACIW and BMY is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.23 |
Correlation (All Time) Calculated using the full available price history since Feb 27, 1995 | 0.21 |
Fundamentals
ACIW:
$4.65B
BMY:
$116.75B
ACIW:
$1.99
BMY:
$3.57
ACIW:
22.79
BMY:
16.02
ACIW:
1.02
BMY:
0.91
ACIW:
2.62
BMY:
2.40
ACIW:
3.10
BMY:
5.82
ACIW:
$1.79B
BMY:
$48.48B
ACIW:
$878.23M
BMY:
$33.33B
ACIW:
$412.16M
BMY:
$13.34B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ACIW vs. BMY — Risk / Return Rank
ACIW
BMY
ACIW vs. BMY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ACI Worldwide, Inc. (ACIW) and Bristol-Myers Squibb Company (BMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ACIW | BMY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.79 | ||
| Sortino ratioReturn per unit of downside risk | -1.10 | ||
| Omega ratioGain probability vs. loss probability | 1.01 | 1.14 | -0.13 |
| Calmar ratioReturn relative to maximum drawdown | -0.12 | 1.53 | -1.65 |
| Martin ratioReturn relative to average drawdown | -0.23 | 3.32 | -3.55 |
Loading charts...
Drawdowns
ACIW vs. BMY - Drawdown Comparison
The maximum ACIW drawdown since its inception was -90.10%, which is greater than BMY's maximum drawdown of -72.03%. Use the drawdown chart below to compare losses from any high point for ACIW and BMY.
Loading charts...
Drawdown Indicators
| ACIW | BMY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -90.10% | -72.03% | -18.07% |
Max Drawdown (1Y)Largest decline over 1 year | -28.25% | -12.05% | -16.20% |
Max Drawdown (3Y)Largest decline over 3 years | -35.02% | -36.85% | +1.83% |
Max Drawdown (5Y)Largest decline over 5 years | -49.40% | -47.67% | -1.73% |
Max Drawdown (10Y)Largest decline over 10 years | -54.18% | -47.67% | -6.51% |
Current DrawdownCurrent decline from peak | -23.58% | -17.79% | -5.79% |
Average DrawdownAverage peak-to-trough decline | -33.86% | -22.38% | -11.48% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.26% | 6.34% | +8.92% |
Volatility
ACIW vs. BMY - Volatility Comparison
ACI Worldwide, Inc. (ACIW) has a higher volatility of 9.29% compared to Bristol-Myers Squibb Company (BMY) at 8.22%. This indicates that ACIW's price experiences larger fluctuations and is considered to be riskier than BMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ACIW | BMY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.29% | 8.22% | +1.07% |
Volatility (6M)Calculated over the trailing 6-month period | 26.94% | 18.18% | +8.76% |
Volatility (1Y)Calculated over the trailing 1-year period | 32.82% | 27.08% | +5.74% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 35.19% | 24.02% | +11.17% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.67% | 25.29% | +10.38% |
Dividends
ACIW vs. BMY - Dividend Comparison
ACIW has not paid dividends to shareholders, while BMY's dividend yield for the trailing twelve months is around 4.38%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ACIW ACI Worldwide, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BMY Bristol-Myers Squibb Company | 4.38% | 4.60% | 4.24% | 4.44% | 3.00% | 2.36% | 3.69% | 2.55% | 3.08% | 2.55% | 1.95% | 2.17% |
Financials
ACIW vs. BMY - Financials Comparison
This section allows you to compare key financial metrics between ACI Worldwide, Inc. and Bristol-Myers Squibb Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ACIW vs. BMY - Profitability Comparison
ACIW - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ACI Worldwide, Inc. reported a gross profit of 197.29M and revenue of 425.75M. Therefore, the gross margin over that period was 46.3%.
BMY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a gross profit of 8.07B and revenue of 11.49B. Therefore, the gross margin over that period was 70.2%.
ACIW - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ACI Worldwide, Inc. reported an operating income of 57.49M and revenue of 425.75M, resulting in an operating margin of 13.5%.
BMY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported an operating income of 3.27B and revenue of 11.49B, resulting in an operating margin of 28.5%.
ACIW - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ACI Worldwide, Inc. reported a net income of 38.31M and revenue of 425.75M, resulting in a net margin of 9.0%.
BMY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bristol-Myers Squibb Company reported a net income of 2.68B and revenue of 11.49B, resulting in a net margin of 23.3%.
Frequently Asked Questions
ACIW and BMY have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ACIW has higher volatility (9.29%) compared to BMY (8.22%). In terms of maximum drawdown, ACIW dropped -90.10% vs BMY's -72.03%.
BMY currently has the higher Sharpe Ratio (0.68 vs -0.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ACIW and BMY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer